Arthrex Vet Systems
Arthrex Vet Systems, a division of privately held Arthrex Inc., develops and sells orthopedic implants, arthroscopy systems, orthobiologics, and imaging platforms for veterinary surgeons treating small and large animals. It serves specialty hospitals, teaching institutions, and wildlife practitioners via direct enterprise field sales.
- Company typePrivate
- Founded1981
- HeadquartersNaples, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Arthrex Vet Systems does
Arthrex Vet Systems is a division of Arthrex Inc., a privately held global orthopedic medical device manufacturer headquartered in Naples, Florida. The division develops and sells veterinary orthopedic surgical products for small animals (dogs, cats) and large animals (primarily horses), spanning five product categories: Small Animal (OrthoLine fracture management, TPLO systems, sutures), Large Animal (Bio-Compression Screws, suture passers, synthetic cartilage grafts), Orthobiologics (IRAP ProEAS, ACP Max PRP, ACP Double-Syringe), Imaging and Resection (Synergy Vision 4K/HDR, SynergyID fluorescence, Nano Arthroscopy, DrillSaw power systems, RF ablation), and Wound Care (JumpStart antimicrobial dressings). The product architecture is platform-based, with the OrthoLine system sharing screw compatibility with TPLO instrumentation and imaging platforms supporting multiple surgical specialties through interchangeable visualization modes.
The company serves veterinary surgeons in small animal and equine practice, specialty referral hospitals, academic veterinary teaching institutions (e.g., Cornell University, Colorado State University partnership), and wildlife/exotic animal practitioners. Revenue is generated through direct B2B hardware sales of proprietary implants and instruments, with a field sales representative model, inside sales via customer service lines, and conference-based engagement at events such as ACVS, AAEP, NAVC VMX, TEVA, and WVC. Pricing is not publicly disclosed; customers obtain quotes by contacting representatives or submitting website inquiries. The go-to-market is reinforced by an extensive continuing education program including ACVS resident training, on-demand CE through OrthoPedia Vet, live webinars, and hands-on labs at the Naples headquarters and partner sites.
The division leverages the parent company's established surgeon collaboration model and human orthopedic R&D infrastructure, with R&D throughput exceeding 1,000 new products and procedures annually. No AI/ML capabilities are evident. The company is privately held with no disclosed revenue, funding rounds, or external ownership events.
Arthrex Vet Systems firmographics
Firmographics- Name
- Arthrex Vet Systems
- Legal name
- Arthrex, Inc.
- Website
- https://arthrexvetsystems.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Arthrex Vet Systems, a division of privately held Arthrex Inc., develops and sells orthopedic implants, arthroscopy systems, orthobiologics, and imaging platforms for veterinary surgeons treating small and large animals. It serves specialty hospitals, teaching institutions, and wildlife practitioners via direct enterprise field sales.
- Ownership category
- akta.pro rank
Arthrex Vet Systems industry classification
Industry- Product category
- Veterinary Orthopedic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics) (HLAMAFAE)
- akta.pro secondary industries
- Surgical & Procedural Instruments (Scalpels, Forceps, Retractors) (HLAMAFAA), Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF), Point-of-Care Regenerative Kits & Devices (Processing/Delivery) (HLAMANAK)
Keywords
Where Arthrex Vet Systems is headquartered
LocationHeadquarters
- HQ city
- Naples
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Arthrex Vet Systems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Orthopedic Implants and Devices: Sale of proprietary orthopedic implants including plates, screws, suture anchors, and arthroscopy instruments to veterinary surgeons and animal hospitals. Products are sold directly through sales representatives and via product catalogs.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Arthrex Vet Systems product offering
Product offeringCore offering
Arthrex Vet Systems develops and manufactures veterinary orthopedic medical devices, implants, and orthobiologic systems for the treatment of small animals (dogs, cats) and large animals (horses). Its portfolio spans fracture plating systems, TPLO instrumentation, arthroscopy and visualization platforms, platelet-rich plasma and IRAP regenerative systems, and wound care dressings, sold to veterinary surgeons, animal hospitals, and academic veterinary centers.
Product overview
Arthrex Vet Systems is a division of Arthrex Inc. that develops veterinary surgical products and solutions for large and small animals. The product portfolio operates as a platform-plus-modules architecture centered around orthopedic surgical systems, with the core OrthoLine Fracture Management System serving as the foundational plating platform that interconnects with the TPLO (Tibial Plateau Leveling Osteotomy) system through compatible screws. The portfolio spans five main categories: (1) Small Animal products including OrthoLine fracture plating systems, TPLO instruments and plates, VetSuture sutures, and cartilage repair solutions; (2) Large Animal products featuring Bio-Compression Screws, cannulated screw systems, and suture management tools; (3) Orthobiologics including IRAP ProEAS System, ACP Max PRP System, and ACP Double-Syringe System for regenerative medicine treatments; (4) Imaging and Resection systems such as Synergy Vision 4K/HDR platform with Pano scope technology, Synergy*ID fluorescence imaging, Nano Arthroscopy, DrillSaw power systems, and radio frequency ablation tools; and (5) Wound Care featuring JumpStart antimicrobial dressings. The integrated nature of the OrthoLine system allows the same screws to be used across both fracture repair and TPLO procedures, while the imaging platforms support multiple surgical specialties through visualization options including standard white light, near-infrared fluorescence, and HDR imaging.
Differentiator
Problem solved
Functional benefit
Products and services
- OrthoLine™ Fracture Management System
Quantifiable outcome
- Successful standing NanoNeedle arthroscopy in horses without general anesthesia, with confirmed soundness and bone remodeling at one-year follow-up
Companies that use Arthrex Vet Systems
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Arthrex Vet Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Arthrex Vet Systems partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Arthrex Vet Systems competitors and assessment
Company assessmentDirect peers
- Securos Surgical (MWI Animal Health / Covetrus): Securos is a long-standing veterinary orthopedic implants and instruments brand now distributed through Covetrus/MWI; it competes head-to-head with Arthrex Vet Systems across fracture plating, TPLO, and cruciate repair systems for small animal surgeons, and represents the most direct channel-level competitor in the US vet specialty market.
- Veterinary Orthopedic Implants (VOI): VOI manufactures and distributes veterinary-specific plates, screws (including locking systems), and TPLO instrumentation for small animal orthopedics, directly overlapping Arthrex Vet Systems' core OrthoLine and TPLO Locking Plate offering.
- IMEX Veterinary Inc. IMEX is a veterinary orthopedic implant specialist offering circular and skeletal external fixators, TPLO plates, and linear fixation systems, serving small animal surgeons with a comparable catalog to Arthrex Vet Systems' fracture and cruciate stabilization portfolio.
- Veterinary Instrumentation: Veterinary Instrumentation is a UK-based supplier of veterinary surgical instruments, implants, and TPLO/cruciate repair systems, frequently used by referral and academic centers alongside or instead of Arthrex Vet Systems in equine and small animal markets.
- Intrauma (Animal Health division): Intrauma manufactures veterinary orthopedic devices (plates, screws, TPLO systems) that overlap with Arthrex Vet Systems' implant catalog and is distributed internationally, providing a similar mid-size specialty player profile.
- Orthomed (UK) Ltd. Orthomed supplies orthopedic implants and instruments for both small animal and equine veterinarians, including plating, TPLO, and external fixation systems, with strong UK and European academic-veterinary relationships analogous to Arthrex Vet Systems' Fort Collins/Colorado State presence.
Broad incumbents
- DePuy Synthes Vet (Johnson & Johnson MedTech): Johnson & Johnson's DePuy Synthes is the dominant human orthopedic trauma and implant franchise and historically enters adjacent veterinary channels through academic/specialty accounts; its brand and R&D resources position it as a broad incumbent threat to specialized veterinary orthopedic players like Arthrex Vet Systems.
- Stryker Corporation (Vet / Animal Health extensions): Stryker is a global medical/surgical equipment powerhouse with selectively applied veterinary offerings (power tools, visualization, sports med implants) that overlap with Arthrex Vet Systems' DrillSaw power systems and arthroscopy/imaging platforms.
Emerging players
- New Generation Devices (NGD): NGD produces veterinary specialty implants including TPLO and craniofacial/maxillofacial plating systems; as a smaller specialist, it competes niche-by-niche with Arthrex Vet Systems' modular OrthoLine and TPLO offerings, especially at price-sensitive clinics.
- BioVinc / Veterinary Regenerative Medicine players: VetStem Biopharma and similar regenerative medicine companies offer autologous stem-cell and PRP services for canine osteoarthritis, overlapping with Arthrex Vet Systems' IRAP ProEAS and ACP Max PRP orthobiologic offerings in small animal joint care.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Arthrex Vet Systems social profiles
Digital presenceArthrex Vet Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arthrex Vet Systems leadership team
Management profileNumber of profiles
Arthrex Vet Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arthrex Vet Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arthrex Vet Systems
What does Arthrex Vet Systems do?
Arthrex Vet Systems develops and manufactures veterinary orthopedic medical devices, implants, and orthobiologic systems for the treatment of small animals (dogs, cats) and large animals (horses). Its portfolio spans fracture plating systems, TPLO instrumentation, arthroscopy and visualization platforms, platelet-rich plasma and IRAP regenerative systems, and wound care dressings, sold to veterinary surgeons, animal hospitals, and academic veterinary centers.
Is Arthrex Vet Systems a public or private company?
Arthrex Vet Systems is a private company. It is classified as corporate owned and is currently operating.
When was Arthrex Vet Systems founded?
Arthrex Vet Systems was founded in 1981. It employs 1,001 to 5,000 people.
Where is Arthrex Vet Systems based?
Arthrex Vet Systems is headquartered in Naples, United States, in the North America region.
How does Arthrex Vet Systems make money?
One revenue line is on record: veterinary Orthopedic Implants and Devices.
Who are Arthrex Vet Systems's main competitors?
Direct peers on record are Securos Surgical (MWI Animal Health / Covetrus), Veterinary Orthopedic Implants (VOI), IMEX Veterinary Inc., Veterinary Instrumentation, Intrauma (Animal Health division) and Orthomed (UK) Ltd.. Broad incumbents are DePuy Synthes Vet (Johnson & Johnson MedTech) and Stryker Corporation (Vet / Animal Health extensions). Emerging players are New Generation Devices (NGD) and BioVinc / Veterinary Regenerative Medicine players.
Does Arthrex Vet Systems have an API?
No public API is recorded for Arthrex Vet Systems.
What industry is Arthrex Vet Systems in?
Arthrex Vet Systems's product category is Veterinary Orthopedic Medical Devices. Its primary akta.pro industry code is HLAMAFAE, Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics), with a secondary code of HLAMAFAA, Surgical & Procedural Instruments (Scalpels, Forceps, Retractors). Its NAICS code is 334510 and its SIC code is 3842.